{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:06:55Z","timestamp":1791994015299,"version":"4.4.0"},"reference-count":61,"publisher":"Portland Press Ltd.","issue":"9","license":[{"start":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T00:00:00Z","timestamp":1619481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0\/"}],"content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,5,14]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Pregnancies complicated by severe, early-onset fetal growth restriction with abnormal Doppler velocimetry (FGRadv) have a sparse villous vascular tree secondary to impaired angiogenesis. As endothelial cell (EC) and stromal matrix interactions are key regulators of angiogenesis, we investigated the role of placental stromal villous matrix on fetoplacental EC angiogenesis. We have developed a novel model of generating placental fibroblast (FB) cell-derived matrices (CDMs), allowing us to interrogate placenta-specific human EC and stromal matrix interactions and their effects on fetoplacental angiogenesis. We found that as compared with control ECs plated on control matrix, FGRadv ECs plated on FGRadv matrix exhibited severe migrational defects, as measured by velocity, directionality, accumulated distance, and Euclidean distance in conjunction with less proliferation. However, control ECs, when interacting with FGRadv CDM, also demonstrated significant impairment in proliferation and migratory properties. Conversely several angiogenic attributes were rescued in FGRadv ECs subjected to control matrix, demonstrating the importance of placental villous stromal matrix and EC-stromal matrix interactions in regulation of fetoplacental angiogenesis.<\/jats:p>","DOI":"10.1042\/cs20201533","type":"journal-article","created":{"date-parts":[[2021,4,27]],"date-time":"2021-04-27T12:40:35Z","timestamp":1619527235000},"page":"1127-1143","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Human placental villous stromal extracellular matrix regulates fetoplacental angiogenesis in severe fetal growth restriction"],"prefix":"10.1042","volume":"135","author":[{"given":"Shuhan","family":"Ji","sequence":"first","affiliation":[{"name":"Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Gumina","sequence":"additional","affiliation":[{"name":"Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"McPeak","sequence":"additional","affiliation":[{"name":"Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Moldovan","sequence":"additional","affiliation":[{"name":"Department of Pharmacology, University of Colorado School of Medicine, Aurora, CO, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam\u00a0D.","family":"Post","sequence":"additional","affiliation":[{"name":"Department of Pathology, University of Colorado School of Medicine, Aurora, CO, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3739-9396","authenticated-orcid":false,"given":"Emily\u00a0J.","family":"Su","sequence":"additional","affiliation":[{"name":"Division of Maternal-Fetal Medicine\/Division of Reproductive Sciences, Department of Obstetrics and Gynecology, University of Colorado School of Medicine, Aurora, CO, U.S.A."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"288","published-online":{"date-parts":[[2021,5,11]]},"reference":[{"key":"2021113011211337000_B1","doi-asserted-by":"publisher","first-page":"e97","DOI":"10.1097\/AOG.0000000000003070","article-title":"ACOG practice bulletin","author":"ACOG","year":"2019","journal-title":"Obstet. Gynecol."},{"key":"2021113011211337000_B2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn","year":"2016","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"2021113011211337000_B3","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.ejogrb.2005.07.008","article-title":"Intrauterine growth restriction and absent or reverse end-diastolic blood flow in umbilical artery (Doppler class II or III): a retrospective study of short- and long-term fetal morbidity and mortality","volume":"126","author":"Gerber","year":"2006","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"2021113011211337000_B4","doi-asserted-by":"publisher","first-page":"420e1","DOI":"10.1016\/j.ajog.2014.07.033","article-title":"Defining the residual risk of adverse perinatal outcome in growth-restricted fetuses with normal umbilical artery blood flow","volume":"211","author":"O'Dwyer","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011211337000_B5","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.bpobgyn.2018.02.009","article-title":"Planning management and delivery of the growth-restricted fetus","volume":"49","author":"Baschat","year":"2018","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"2021113011211337000_B6","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/uog.12388","article-title":"Childhood cognitive development after fetal growth restriction","volume":"41","author":"Llurba","year":"2013","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"2021113011211337000_B7","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/1471-0528.13435","article-title":"Differential effect of intrauterine growth restriction on childhood neurodevelopment: a systematic review","volume":"122","author":"Murray","year":"2015","journal-title":"BJOG"},{"key":"2021113011211337000_B8","doi-asserted-by":"publisher","first-page":"F322","DOI":"10.1136\/adc.2007.120485","article-title":"Neurocognitive outcome following fetal growth restriction","volume":"93","author":"Walker","year":"2008","journal-title":"Arch. Dis. Child. Fetal Neonatal Ed."},{"key":"2021113011211337000_B9","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.bpobgyn.2016.08.005","article-title":"Early onset fetal growth restriction","volume":"38","author":"Nawathe","year":"2017","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"key":"2021113011211337000_B10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/S1470-0328(02)02514-4","article-title":"A randomised trial of timed delivery for the compromised preterm fetus: short term outcomes and Bayesian interpretation","volume":"110","author":"Growth Restriction Intervention Trial Group","year":"2003","journal-title":"BJOG"},{"key":"2021113011211337000_B11","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/S0140-6736(04)16809-8","article-title":"Infant wellbeing at 2 years of age in the Growth Restriction Intervention Trial (GRIT): multicentred randomised controlled trial","volume":"364","author":"Thornton","year":"2004","journal-title":"Lancet"},{"key":"2021113011211337000_B12","doi-asserted-by":"publisher","first-page":"34e1","DOI":"10.1016\/j.ajog.2010.09.019","article-title":"The Growth Restriction Intervention Trial: long-term outcomes in a randomized trial of timing of delivery in fetal growth restriction","volume":"204","author":"Walker","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011211337000_B13","doi-asserted-by":"publisher","first-page":"2162","DOI":"10.1016\/S0140-6736(14)62049-3","article-title":"2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial","volume":"385","author":"Lees","year":"2015","journal-title":"Lancet"},{"key":"2021113011211337000_B14","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S2352-4642(17)30173-6","article-title":"Maternal sildenafil for severe fetal growth restriction (STRIDER): a multicentre, randomised, placebo-controlled, double-blind trial","volume":"2","author":"Sharp","year":"2018","journal-title":"Lancet Child Adolesc. Health"},{"key":"2021113011211337000_B15","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1111\/1471-0528.15658","article-title":"STRIDER NZAus: a multicentre randomised controlled trial of sildenafil therapy in early-onset fetal growth restriction","volume":"126","author":"Groom","year":"2019","journal-title":"BJOG"},{"key":"2021113011211337000_B16","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-23941-0","volume-title":"Pathology of the Human Placenta","author":"Bernirschke","year":"2012"},{"key":"2021113011211337000_B17","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1046\/j.1469-0705.1997.09040271.x","article-title":"Pathology and clinical implications of abnormal umbilical artery Doppler waveforms","volume":"9","author":"Kingdom","year":"1997","journal-title":"Ultrasound Obstet. Gynecol."},{"key":"2021113011211337000_B18","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.placenta.2003.10.010","article-title":"Aspects of human fetoplacental vasculogenesis and angiogenesis. III. Changes in complicated pregnancies","volume":"25","author":"Mayhew","year":"2004","journal-title":"Placenta"},{"key":"2021113011211337000_B19","doi-asserted-by":"publisher","first-page":"E30","DOI":"10.1210\/jc.2014-2385","article-title":"Impaired fetoplacental angiogenesis in growth-restricted fetuses with abnormal umbilical artery doppler velocimetry is mediated by aryl hydrocarbon receptor nuclear translocator (ARNT)","volume":"100","author":"Su","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"2021113011211337000_B20","first-page":"499","article-title":"Umbilical Doppler waveforms and placental villous angiogenesis in pregnancies complicated by fetal growth restriction","volume":"93","author":"Todros","year":"1999","journal-title":"Obstet. Gynecol."},{"key":"2021113011211337000_B21","doi-asserted-by":"publisher","first-page":"R9","DOI":"10.1530\/JME-17-0139","article-title":"Molecular and cellular underpinnings of normal and abnormal human placental blood flows","volume":"60","author":"Li","year":"2018","journal-title":"J. Mol. Endocrinol."},{"key":"2021113011211337000_B22","doi-asserted-by":"publisher","first-page":"S123","DOI":"10.1016\/j.ajog.2015.06.038","article-title":"Role of the fetoplacental endothelium in fetal growth restriction with abnormal umbilical artery Doppler velocimetry","volume":"213","author":"Su","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011211337000_B23","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1042\/CS20190381","article-title":"Overexpression of the aryl hydrocarbon receptor nuclear translocator partially rescues fetoplacental angiogenesis in severe fetal growth restriction","volume":"133","author":"Ji","year":"2019","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011211337000_B24","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.2741\/3173","article-title":"Tumor microenvironment and angiogenesis","volume":"13","author":"Nyberg","year":"2008","journal-title":"Front. Biosci."},{"key":"2021113011211337000_B25","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1007\/978-3-319-78127-3_6","article-title":"Stromal cells in the tumor microenvironment","volume":"1060","author":"Denton","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"2021113011211337000_B26","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1053\/plac.2002.0900","article-title":"Stereological investigation of placental morphology in pregnancies complicated by pre-eclampsia with and without intrauterine growth restriction","volume":"24","author":"Mayhew","year":"2003","journal-title":"Placenta"},{"key":"2021113011211337000_B27","doi-asserted-by":"publisher","first-page":"398","DOI":"10.1002\/pd.323","article-title":"Stereological quantification of placental villus vascularization and its relation to umbilical artery Doppler flow in intrauterine growth restriction","volume":"22","author":"Sagol","year":"2002","journal-title":"Prenat. Diagn."},{"key":"2021113011211337000_B28","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/0892-0354(91)90019-9","article-title":"Ultrastructure of the normal human placenta","volume":"4","author":"Jones","year":"1991","journal-title":"Electron Microsc. Rev."},{"key":"2021113011211337000_B29","doi-asserted-by":"publisher","first-page":"e150","DOI":"10.1097\/AOG.0000000000002046","article-title":"ACOG Committee Opinion No. 700: methods for estimating the due date","volume":"129","author":"The American College of Obstetricians and Gynecologists.","year":"2017","journal-title":"Obstet. Gynecol."},{"key":"2021113011211337000_B30","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1095\/biolreprod.106.059451","article-title":"Regulation of 17-beta hydroxysteroid dehydrogenase type 2 in human placental endothelial cells","volume":"77","author":"Su","year":"2007","journal-title":"Biol. Reprod."},{"key":"2021113011211337000_B31","doi-asserted-by":"publisher","first-page":"427e1","DOI":"10.1016\/j.ajog.2009.01.025","article-title":"Estrogen receptor-beta mediates cyclooxygenase-2 expression and vascular prostanoid levels in human placental villous endothelial cells","volume":"200","author":"Su","year":"2009","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011211337000_B32","doi-asserted-by":"publisher","first-page":"2376","DOI":"10.1038\/nprot.2017.107","article-title":"Cell-derived matrices for studying cell proliferation and directional migration in a complex 3D microenvironment","volume":"12","author":"Kaukonen","year":"2017","journal-title":"Nat. Protoc."},{"key":"2021113011211337000_B33","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1080\/08820130600754960","article-title":"More than structural cells, fibroblasts create and orchestrate the tumor microenvironment","volume":"35","author":"Baglole","year":"2006","journal-title":"Immunol. Invest."},{"key":"2021113011211337000_B34","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.1177\/1947601911432334","article-title":"Molecular mechanisms of tumor angiogenesis","volume":"2","author":"Ziyad","year":"2011","journal-title":"Genes Cancer"},{"key":"2021113011211337000_B35","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1111\/j.1365-2567.2005.02265.x","article-title":"CD45: all is not yet crystal clear","volume":"117","author":"Holmes","year":"2006","journal-title":"Immunology"},{"key":"2021113011211337000_B36","doi-asserted-by":"publisher","first-page":"1911","DOI":"10.3389\/fimmu.2017.01911","article-title":"Chondroitin sulfate proteoglycan 4 and its potential as an antibody immunotherapy target across different tumor types","volume":"8","author":"Ilieva","year":"2017","journal-title":"Front. Immunol."},{"key":"2021113011211337000_B37","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1053\/plac.2002.0904","article-title":"Placental extracellular matrix: gene expression, deposition by placental fibroblasts and the effect of oxygen","volume":"24","author":"Chen","year":"2003","journal-title":"Placenta"},{"key":"2021113011211337000_B38","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1007\/s12015-020-09959-8","article-title":"Mesenchymal stem\/stromal cells from the placentae of growth restricted pregnancies are poor stimulators of angiogenesis","volume":"16","author":"Umapathy","year":"2020","journal-title":"Stem Cell Rev. Rep."},{"key":"2021113011211337000_B39","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1111\/j.1471-0528.1995.tb10849.x","article-title":"Sonographic, stereological and Doppler flow velocimetric assessments of placental maturity","volume":"102","author":"Burton","year":"1995","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"2021113011211337000_B40","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1053\/plac.2002.0865","article-title":"Fetoplacental angiogenesis during gestation is biphasic, longitudinal and occurs by proliferation and remodelling of vascular endothelial cells","volume":"23","author":"Mayhew","year":"2002","journal-title":"Placenta"},{"key":"2021113011211337000_B41","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-23941-0","volume-title":"Pathology of the Human Placenta","author":"Benirschke","year":"2012"},{"key":"2021113011211337000_B42","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1016\/0002-9378(89)90528-0","article-title":"Doppler velocimetry and placental disease","volume":"161","author":"Bracero","year":"1989","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011211337000_B43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/j.1471-0528.1985.tb01045.x","article-title":"Fetal umbilical artery flow velocity waveforms and placental resistance: pathological correlation","volume":"92","author":"Giles","year":"1985","journal-title":"Br. J. Obstet. Gynaecol."},{"key":"2021113011211337000_B44","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/S0002-9378(87)80082-0","article-title":"Umbilical artery flow velocity waveforms and the placental vascular bed","volume":"157","author":"McCowan","year":"1987","journal-title":"Am. J. Obstet. Gynecol."},{"key":"2021113011211337000_B45","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/S0143-4004(82)80004-0","article-title":"A three-dimensional study of the normal human placental villous core: II. Stromal architecture","volume":"3","author":"Castellucci","year":"1982","journal-title":"Placenta"},{"key":"2021113011211337000_B46","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/BF01457655","article-title":"Placental villous stroma as a model system for myofibroblast differentiation","volume":"105","author":"Kohnen","year":"1996","journal-title":"Histochem. Cell Biol."},{"key":"2021113011211337000_B47","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1007\/BF00226964","article-title":"Scanning electron microscopy of stromal cells of human placental villi throughout pregnancy","volume":"235","author":"Martinoli","year":"1984","journal-title":"Cell Tissue Res."},{"key":"2021113011211337000_B48","doi-asserted-by":"publisher","first-page":"a006676","DOI":"10.1101\/cshperspect.a006676","article-title":"The role of the tumor microenvironment in regulating angiogenesis","volume":"2","author":"Watnick","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2021113011211337000_B49","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/j.1538-7836.2007.02569.x","article-title":"Cell-matrix adhesion in vascular development","volume":"5","author":"Hynes","year":"2007","journal-title":"J. Thromb. Haemost."},{"key":"2021113011211337000_B50","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1126\/science.1176009","article-title":"The extracellular matrix: not just pretty fibrils","volume":"326","author":"Hynes","year":"2009","journal-title":"Science"},{"key":"2021113011211337000_B51","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nrc2561","article-title":"Regulation of nitric oxide signalling by thrombospondin 1: implications for anti-angiogenic therapies","volume":"9","author":"Isenberg","year":"2009","journal-title":"Nat. Rev. Cancer"},{"key":"2021113011211337000_B52","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/71517","article-title":"Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1","volume":"6","author":"Jimenez","year":"2000","journal-title":"Nat. Med."},{"key":"2021113011211337000_B53","doi-asserted-by":"publisher","first-page":"a006627","DOI":"10.1101\/cshperspect.a006627","article-title":"Molecular basis for the regulation of angiogenesis by thrombospondin-1 and -2","volume":"2","author":"Lawler","year":"2012","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"2021113011211337000_B54","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1091\/mbc.e04-12-1082","article-title":"Hypoxia-inducible factor regulates alphavbeta3 integrin cell surface expression","volume":"16","author":"Cowden Dahl","year":"2005","journal-title":"Mol. Biol. Cell"},{"key":"2021113011211337000_B55","doi-asserted-by":"publisher","first-page":"11530","DOI":"10.18632\/oncotarget.3448","article-title":"Down-regulation of ARNT promotes cancer metastasis by activating the fibronectin\/integrin beta1\/FAK axis","volume":"6","author":"Huang","year":"2015","journal-title":"Oncotarget"},{"key":"2021113011211337000_B56","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/bs.apha.2017.08.002","article-title":"Matrix metalloproteinases, vascular remodeling, and vascular disease","volume":"81","author":"Wang","year":"2018","journal-title":"Adv. Pharmacol."},{"key":"2021113011211337000_B57","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1161\/01.RES.0000191547.64391.e3","article-title":"Endothelial extracellular matrix: biosynthesis, remodeling, and functions during vascular morphogenesis and neovessel stabilization","volume":"97","author":"Davis","year":"2005","journal-title":"Circ. Res."},{"key":"2021113011211337000_B58","doi-asserted-by":"publisher","first-page":"13546","DOI":"10.1038\/ncomms13546","article-title":"PPFIA1 drives active alpha5beta1 integrin recycling and controls fibronectin fibrillogenesis and vascular morphogenesis","volume":"7","author":"Mana","year":"2016","journal-title":"Nat. Commun."},{"key":"2021113011211337000_B59","doi-asserted-by":"publisher","first-page":"2146e5","DOI":"10.1016\/j.cub.2020.03.042","article-title":"RhoJ regulates alpha5beta1 integrin trafficking to control fibronectin remodeling during angiogenesis","volume":"30","author":"Sundararaman","year":"2020","journal-title":"Curr. Biol."},{"key":"2021113011211337000_B60","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1055\/s-0035-1570379","article-title":"Role of the placenta in preterm birth: a review","volume":"33","author":"Morgan","year":"2016","journal-title":"Am. J. Perinatol."},{"key":"2021113011211337000_B61","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.52004","article-title":"Single cell transcriptional signatures of the human placenta in term and preterm parturition","volume":"8","author":"Pique-Regi","year":"2019","journal-title":"Elife"}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/9\/1127\/911030\/cs-2020-1533.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/135\/9\/1127\/911030\/cs-2020-1533.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T12:17:57Z","timestamp":1638274677000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/135\/9\/1127\/228465\/Human-placental-villous-stromal-extracellular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":61,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,5,14]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20201533","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2021,5]]},"published":{"date-parts":[[2021,5]]}}}